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The Making of a Pathogen: Impacts of Phage Domestication in Acinetobacter baumannii
Introduction
Populations of bacteria continue to change and new pathogens have consequently emerged.
As bacterial pathogens evolve, an increasing number of virulence factors are acquired.
One of the most significant changes in the bacterial population is due to the introduction of
antibiotics and subsequent increase in antibiotic resistance. This problem poses a
significant threat to human health. Until new antibiotics are created or novel therapeutic
strategies are implemented, humans are rendered defenseless during infection. The species
Acinetobacter baumannii has undergone significant changes and is now recognized as one of
the most threatening pathogens due to its high antibiotic resistance profile. What was once
an innocuous environmental organism is now one of the greatest clinical threats. With a
growing prominence in healthcare, the evolution of A. baumannii is particularly unique; to
better understand the rise to its present state, several clinical isolates of A. baumannii were
analyzed to discern the changes that have occurred to contribute to its pathogenicity. Upon
analysis, several intact and incomplete prophages were discovered that were contained
within the bacterial chromosome. Remnants of these bacterial viruses have been shown to
be advantageous in a number of other bacteria, but no relationship to A. baumannii has
been previously described. In response to these changes, the conservation of bacteriophage
genes was assessed in relation to the current increase in antibiotic resistance and virulence
of Acinetobacter baumannii.
Bacteriophages are bacterial viruses that naturally infect bacteria, integrating their own
genetic information into the bacterial genome and become prophages. By using bacteria as
a host, prophages multiply with bacteria through replication. Through lysis of the
bacterium, bacteriophages are removed from the bacterial genome, killing their host.
Despite this parasitic relationship, the inclusion of bacteriophage genes within a genome
has the potential to increase the virulence of the bacteria. Due to these beneficial changes
in pathogenicity, bacteria have selected for these advantageous modifications. Some
species have even maintained defective phages within their genome, corresponding to
progressive increases in virulence across the bacterial population. Unlike other nonpathogenic Acinetobacter species, A. baumannii has maintained greater numbers of
incomplete prophages within its genome, particularly that of Acinetobacter phage BϕB1251. The acquisition and maintenance of defective phage elements appears to be
increasing over time, suggesting that A. baumannii has undergone a directional evolution,
selecting for the advantages bacteriophage genes confer.
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I. PATHOGENICITY AND ANTIBIOTIC RESISTANCE
The coexistence of humans and microorganisms has historically been documented,
accepted, and understood. But the human relationship with bacteria is not as straightforward as
some believe. As we continue to elucidate the intricacies of our connectedness with bacteria,
these organisms continue to change. Humans have a propensity to solely associate bacteria with
infections; despite the bad reputation of bacteria, they also contribute to a number of beneficial
human interactions. The human body contains a number of microbial environments, including
the skin, respiratory tract, gastrointestinal tract, and conjunctiva of the eyes. In total, these
environments contain approximately 1014 bacteria, ten times the number of human cells within
the body (Davis, 1996). During birth, bacteria begin to colonize these sites. While the types of
bacteria contained within the body continue to fluctuate, one thing remains the same: these
bacteria are essential for health. By competing with pathogenic species for nutrients, the normal
bacterial flora prevent the colonization of harmful bacteria. Others produce enzymes, such as
proteases, peroxides, and bacteriocins capable of killing invading bacteria and denaturing
harmful bacterial toxins (Quigley, 2013).
While bacteria certainly confer great health advantages, not all species are beneficial.
The term “pathogens” is applied to these species that are capable of causing disease. Bacteria
have been implicated as pathogens throughout the course of history; lethal plagues have
decimated empires and resulted in the fall of rulers. The first recorded plague, the Great
Pestilence of Egypt, occurred in 3180 BC and is documented in the Bible (Krause, 1992). Since
this time, outbreaks of bacteria continue to be noted and have caused epidemics that unceasingly
altered the course of history. The human background is characterized by these microbiological
threats and outbreaks such as the Bubonic Plague, cholera, typhoid fever, diphtheria, leprosy, and
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anthrax attacks. Not only have these events caused widespread fear and significant deaths, but
they have also ushered in greater scientific understanding and have prompted the development of
treatments and therapeutics.
Even among pathogens, some are more destructive than others. The degree of
pathogenicity, the ability to cause disease, is termed virulence. Bacteria have developed a
number of mechanisms to increase their pathogenicity. Broadly, two factors are analyzed to
describe bacterial virulence: toxicity and invasiveness. Toxicity describes the degree of harm
while invasiveness describes the ability to penetrate and spread throughout a host (Beceiro,
Tomás, & Bou, 2013). These factors are essential in order to overcome the protective barriers of
a host, including the populations of bacteria contained within a host. Nevertheless, host status is
another critical factor that must be considered when discussing pathogenicity. Some organisms
are only capable of infecting immunosuppressed individuals, those with weakened immune
systems due to chronic illness, age, diet, and stress. Pathogens that are incapable of causing
infection in healthy people, but do cause infection in immunocompromised individuals are
termed “opportunistic” pathogens.
Despite the devastation associated with bacterial illness, the discovery of antibiotics
promised a new era of protection from bacterial pathogens. When Alexander Fleming first
discovered the effects of penicillin in 1928, the microbial world was transformed and a sense of
hope emerged (Fleming, 1944). When Fleming noticed that a mold contaminant introduced into
his cultures of Staphylococcus aureus killed his bacteria, he was prompted to begin studying this
strange occurrence. It took many years for this compound to be successfully isolated before it
was first used clinically in 1941 by Charles Fletcher (Fletcher, 1984). The antibiotic penicillin
was first introduced into routine hospital procedures by the Mayo Clinic in 1943 in order to treat
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patients with bacterial infections (Herrell, 1944). Since this time, hundreds of antibiotics have
been developed. These antibiotics range in effectiveness, some treating specific classes of
bacteria (narrow-spectrum) while others target many classes of bacteria (broad-spectrum).
Antibiotics have become an integral component to healthcare; without antibiotics,
bacteria would be remarkably more devastating for humans. Before antibiotics were used as
treatment, 30% of all deaths were attributable to bacterial infections (Fair & Tor, 2014). Today,
this number is significantly lower. By reducing infections, hospital stays, and mortality rates,
antibiotics are necessary to improve patient outcome. Despite their apparent promise, what once
protected the health of millions is now not always a reliable treatment option. We have used
antibiotics for many years and have reaped the benefits they provide in controlling disease.
However, this reliance has yielded consequences; bacteria have been exposed to the same
antibiotics for so long that they have adapted to these medications. The evasion and antagonistic
ability bacteria have developed against antibiotics has been exacerbated by the acquisition of
resistance mechanisms across bacterial populations. This alarming trend has been compounded
by inappropriate antibiotic use in healthcare and agriculture (Demirjian, 2015).
With time and exposure to antibiotics, bacteria continue to acquire resistance at a
disconcerting rate. When antibiotics are not used by the body—due to incorrect or unnecessary
prescriptions—increasing amounts are released into the environment and to bacterial populations
within the body. Not only do excess antibiotics often kill healthy, beneficial bacteria, they also
select for strains of bacteria that are most resistant. When faced with antibiotics, only those
strains harboring resistance genes or possessing beneficial mutations are able to survive. These
bacteria proliferate and take the place of susceptible bacteria, expanding the resistant population
(Bearson & Brunelle, 2015). Increasing amounts of resistant bacteria also lead to increased
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opportunities to transfer these genes to other bacteria in the environment, as resistance genes can
be transmitted to other organisms through horizontal gene transfer.
Antibiotic resistance has become one of the most serious threats of our time, but society
and some healthcare workers often overlook its prevalence. Every year approximately two
million people become infected with bacteria that are resistant to antibiotics; of these infections,
about 23,000 people die as a direct result of infection (Demirjian, 2015). When bacteria develop
resistance to some antibiotics, we must turn to other antibiotics. This progression continues until
bacteria ultimately become resistant to all antibiotics. Because no approved alternative options
exist for treatment of bacterial infections, we are left defenseless.
Unfortunately, antibiotic-resistant organisms have adapted and acquired mechanisms that
allow for survival, counteracting the mechanisms antibiotics use to kill or inhibit bacterial
growth. These organisms have undoubtedly become one of the largest threats to healthcare by
becoming progressively more difficult to treat. Because these resistant organisms are not easily
eradicated, they can also be rapidly spread throughout hospitals. These problems impact every
aspect of healthcare; approximately $20 billion of excess is spent to treat antibiotic-resistant
infections (Fair & Tor, 2014). On average in the United States, patients suffering from these
infections spend a total of 8 million extra days in the hospital and antibiotics comprise over 30%
of pharmacy budgets (Fair & Tor, 2014).

II. BACTERIOPHAGES
Just as humans become infected with bacteria and viruses, bacteria are also face natural
predators in the form of bacterial viruses: bacteriophages. These viral particles exploit bacterial
cells for growth, integrating their own genetic information into the genome of bacteria. Once the
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bacteriophage genetic information has been incorporated into the bacterial genome, this genetic
material is termed a “prophage.” These viruses may be lytic, quickly killing their host after
replication, or they may remain lysogenic, entering a period of dormancy. During the lysogenic
cycle, phage DNA is integrated within bacterial chromosomes, replicating alongside host DNA
(Fortier & Sekulovic, 2013).
Despite their destructive nature, both bacteriophages and bacteria confer some natural
benefit to one another. Bacteriophages profit from promoting the survival and proliferation of
their bacterial hosts; when bacteria are killed, the phages they contain are also harmed.
Bacteriophages rely on the health and replication of their hosts in order to produce more viral
particles. During lysogeny, bacteria often acquire enhanced fitness through increased virulence,
pathogenicity, and stress tolerance (Fortier & Sekulovic, 2013). Due to these advantageous
changes, the host is protected against further phage infection and phagocytosis. Bacteriophages
also encode accessory genes that increase host fitness; these include increased growth under
nutrient limitation, biofilm formation, and antibiotic tolerance. Some prophages also encode
regulatory switches, influencing gene expression (Bobay, Touchon, & Rocha, 2014).
In addition, bacteriophages also increase horizontal gene flow throughout the entire
bacterial population, allowing genetic information to be more easily transferred between
organisms (Chen, Golding, Sawai, Guo, & Cox, 2005). Because bacteriophages are the most
abundant organisms on Earth—ten times more abundant than bacteria—they harbor a substantial
amount of genetic information. Approximately 20% of all bacterial genomes are derived from
bacteriophage DNA. Of this information, a large amount confers resistance to antibiotics,
enhances conjugation and biofilm formation, and also helps to endure a number of environmental
stresses (Wang et al., 2010). Bacteriophages are the single largest contributor to horizontal
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(lateral) gene transfer—transfer of genetic information between two organisms. Therefore,
bacteriophages promote bacterial diversity; due to the presence and position of prophages or
phage-like elements, virtually every strain of bacteria is unique. Almost every organism has
been found to contain prophages or harbor genes derived from bacteriophages (Wang et al.,
2010).
In order to sustain this massive population, it is necessary for phages to ensure their own
survival and proliferation; this could not be done without their bacterial hosts. If bacteriophages
were solely harmful, bacteria would slowly adapt to resist phage attack. Because phages do
often benefit their host, bacteria continue to select for the advantageous features that prophages
provide (Feiner et al., 2015). In this manner, bacteria maintain these favorable traits and
“domesticate” their prophages. However, these domesticated elements are often removed from
the bacterial genome when they are replaced by similar traits carried by new prophages.
Therefore, the bacterial genome remains in a state of continuously shifting state of acquisition
and loss of phage-derived genes (Bobay et al., 2014).
Bacteriophages represent a major vector of bacterial genetic diversity, creating
increasingly harmful pathogens. A number of studies utilizing genome mining and comparative
genomics have demonstrated the pervasiveness of prophages in the majority of bacterial
genomes. Not only have prophages impacted the divergence of different bacterial species, but
they also account for significant intra-species variation in pathogenicity and virulence (Wang et
al., 2010). The virulence of many species of bacteria—including Escherichia coli, Streptococcus
pyogenes, Salmonella enterica, and Staphylococcus aureus—is due to acquisition of prophages
and phage genes (Fortier & Sekulovic, 2013). Escherichia coli strain O157:H7, the causative
agent of entero-hemorrhagic food poisoning, is especially virulent due to the acquisition of two
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prophages. These two prophages, Sp5 and Sp15, both encode Shiga-toxin production in E. coli
O157:H7, resulting in the devastating virulence of this pathogen (Fortier & Sekulovic, 2013).
Likewise, Vibrio cholerae, the causative agent of cholera, is only able to secrete cholera toxin
(CT) due to the inclusion of filamentous phage CTXφ within its genome. When pandemic
strains of V. cholerae were compared to environmental non-toxigenic El Tor strains of V.
cholerae, it was discovered that the El Tor strain lacked the CTXφ prophage (Canchaya,
Fournous, & Brussow, 2004). Prophages have also been demonstrated to have similar effects on
other organisms, including Corynebacterium diptheriae, Clostridium botulinum, Staphylococcus
aureus, and others (Chen et al., 2005). Phage genes have been found to encode toxins, effector
proteins, and enzymes including superoxide dismutase, staphylokinase, phospholipase, adhesion
factors, and proteins involved in resistance (Fortier & Sekulovic, 2013). Therefore, the presence
of prophages within a bacterial genome certainly does have a profound effect of the virulence of
an organism, even among the same species.
Through time, prophages may not remain active and capable of lysis. In fact, a number
of prophages are impacted by mutations that occur in bacterial genomes. When segments of the
prophage are deleted or only certain genes are maintained through replication, a prophage
becomes inactive—referred to as a “cryptic” prophage. Despite their incomplete nature, these
phage remnants still impact the pathogenicity and virulence of their host. However, these events
may not be random occurrences. Louis-Marie Bobay, Marie Touchon, and Eduardo Rocha
introduced the concept of phage domestication in 2014. In this study, the dynamics of prophage
degradation were analyzed during vertical gene transfer (from parent to offspring). It was found
that certain phage sequences were maintained throughout replicative events, including phage
sequences coding for certain phage functions, particularly tail and lysis proteins (Bobay et al.,
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2014). This study concluded that phage domestication was adaptive to individual bacteria, but
advantageous additions were maintained by purifying selection (Bobay et al., 2014).
A number of virulence mechanisms have been discovered to result from the maintenance
of incomplete prophages in bacterial genomes; these conserved genes can still produce phage
killer particles and R/F-type bacteriocins that are capable of killing sensitive cells. Cryptic
prophages may still be capable of forming transducing particles, phages carrying host DNA in
place of their own, as well as gene transfer agents (GTAs) that allow for exchange of genetic
material between bacteria. Also, incomplete prophages present in the genome may interrupt
assembly of other phages or bacterial functions (Bobay et al., 2014).
The impact of cryptic prophages on pathogenicity can be demonstrated by analyzing the
genome of Escherichia coli. This well-known species of bacteria is significantly different than
its closest relative, Salmonella. In particular, the K-12 strain of E. coli has gained 18% of its
genetic information since it diverged from Salmonella 100 million years ago (Wang et al., 2010).
This novel information is primarily due to bacteriophages. K-12 contains one complete Lambda
prophage and nine cryptic prophages. In a previous study, when all of these prophage elements
were deleted, this strain became susceptible to one half of the normal minimum inhibitory
concentration (MIC) of quinolone and β-lactam antibiotics, and its ability to form biofilms was
greatly diminished. In addition, this modified strain displayed lower rates of growth in nutrientpoor and nutrient-rich media as well as decreased temperatures. Therefore, cryptic phage
elements also confer increased resistance to antibiotics and enhanced growth in stressful
environments (Wang et al., 2010).
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III. ANTIBIOTIC RESISTANCE: CURRENT THREATS
Monitoring of antibiotic resistance potential is essential in dictating treatment solutions
and observing the evolution of bacteria. The Centers for Disease Control (CDC) has published
guidelines defining “Urgent,” “Serious,” and “Concerning” threats. There are currently eighteen
organisms identified and categorized by the CDC. Of these three classifications, three species of
bacteria receive the highest level of public health attention: urgent. These bacteria are either
causing severe outbreaks or have high potential of causing outbreaks. Immediate public health
intervention must be taken to limit transmission of these species, as they are difficult to prevent
and increasingly difficult to treat. These three antibiotic-resistant species are Clostridium
difficile, carbapenem-resistant Enterobacteriaceae (CRE), and Neisseria gonorrheae (Prevention,
2013).
Unlike urgent threats, serious threats will not immediately become public health threats,
but are expected to worsen to become urgent with declining availability of antibiotic options.
These threats include: multidrug-resistant Acinetobacter, drug-resistant Campylobacter,
fluconazole-resistant Candida, extended spectrum β-lactamase producing Enterobacteriaceae
(ESBLs), vancomycin-resistant Enterococcus (VRE), multidrug-resistant Pseudomonas
aeruginosa, drug-resistant non-typhoidal Salmonella, drug-resistant Salmonella typhi, drugresistant Shigella, methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant
Streptococcus pneumoniae, and multidrug-resistant (MDR) and extensively drug-resistant
(XDR) tuberculosis (Prevention, 2013).
Bacteria listed in the “concerning” category cause serious illness; while these organisms
are resistant to a number of drugs, they remain sensitive to many therapeutic options. Once the
functionality of these drugs are jeopardized, these organisms could become urgent threats. This
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group includes vancomycin-resistant Staphylococcus aureus, erythromycin-resistant Group A
Streptococcus, and clindamycin-resistant Group B Streptococcus (Prevention, 2013).
The World Health Organization also warns of the dangers of antibiotic resistance. They
characterize antibiotic resistance as one of the three most pressing problems impacting human
health. The acronym ESKAPE has been developed to warn of six of the most serious multi-drug
resistant organisms threatening healthcare: Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter
spp. (Howard, O'Donoghue, Feeney, & Sleator, 2012). These species of bacteria comprise the
causes of the majority of nosocomial (hospital-acquired) infections and are particularly difficult
to control within the hospital setting.

IV. THE EMERGENCE OF ACINETOBACTER BAUMANNII
Within the span of a few years, Acinetobacter baumannii has become ubiquitous in
healthcare, capable of causing a number of infections. Recognized as a “serious” threat by the
Centers for Disease Control, this species of bacteria had not become widely recognized until
recently. This species is an opportunistic pathogen, infecting critically ill and
immunocompromised individuals, including newborns, elderly, pregnant women, and other
diseased individuals. A. baumannii is characterized as a strictly aerobic, non-fermenting, nonfastidious, non-motile, catalase-positive, oxidase-negative Gram-negative cocco-bacillus
(Howard et al., 2012). It is not a member of the normal flora of the skin or other human
environments, meaning that it is considered a true pathogen when isolated from human sources.
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A. baumannii is capable of causing a number of infections, often targeting moist tissue,
such as mucous membranes (Howard et al., 2012). While A. baumannii most commonly causes
community- and hospital-acquired pneumonia, it is also a notable cause of meningitis,
bacteremia, wound infections, and urinary tract infections, with minor implications in other
infections. Due to its unique ability to form biofilms, it is capable of colonizing the surface of
the lungs, endotracheal tubes, urinary tract, and the eyes, resisting extraction by mechanical
defenses such as coughing, urination, and blinking (Peleg, Seifert, & Paterson, 2008). Biofilms
are colonies of bacterial that aggregate together and form a community physically held together
by an extracellular polymeric substance (EPS) matrix (Donlan, 2002). Biofilms require exposed
surfaces for attachment, but once formed, become sturdy masses of bacteria that resist
mechanical removal and chemical destruction, including death by antibiotics. The formation of
biofilms makes this pathogen especially threatening in a hospital environment, as it can colonize
all surfaces in hospitals including counters, ventilation tubes, and catheters.
The presence of A. baumannii is also felt within our own community. A. baumannii is a
frequently encountered pathogen in hospitals in Louisville, Kentucky, and has been notable for
many years. The occurrence of this pathogen was analyzed at one single hospital in Louisville
beginning in 2010. Considering the number of hospitals found in this one city, the impact of A.
baumannii is actually much greater in this community. While it is associated with a number of
varying infections at one specific hospital, it is most commonly associated with respiratory and
wound infections (Table 1). Unfortunately, this data does not reflect the increasing rates of
multi-drug resistant Acinetobacter in this hospital. Although the numbers of infections do not
change significantly each year, based on this data, it is likely that a greater percentage of those
isolated in 2016 are multi-drug resistant than the percentage seen in 2010.
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The first strain of Acinetobacter was isolated from the soil in 1911, originally named
Micrococcus calco-aceticus. The name of this organism was officially changed in 1971 to
Acinetobacter, and today this genome comprises 48 species. Members of this genus are
commonly isolated in the environment in soil and water, with the exception of A. baumannii.
The species A. baumannii has yet to be isolated in the environment; rather, it is routinely isolated
in hospital settings as a pathogen (Howard et al., 2012). The genus Acinetobacter remained
largely innocuous throughout history, only isolated from the environment; the emergence of A.
baumannii as a pathogen in the past few decades symbolized a significant shift. The first clinical
account of A. baumannii was published by Schaub and Hauber in “A Biochemical and
Serological Study of a Group of Identical Unidentifiable Gram-negative Bacilli from Human
Sources” in 1948. The organisms in this study were originally identified as Neisseria species
until it was noted that they failed to reduce nitrates. Rather than recognizing these species to be
A. baumannii at this time, these isolates were referred to as Bacterium antinatratum and later
identified to be a pathogenic Acinetobacter species (Schaub & Hauber, 1948).
Since 1948, this species has become increasingly more recognized in healthcare. In an
article written in 1996 by Bergogne-Bérézin and Towner, A. baumannii was still described as a
“relatively low-grade pathogen” (Bergogne-Bérézin & Towner, 1996). However, this pathogen
has been gaining much more respect due to its successful virulence mechanisms and extensive
antibiotic resistance profile, resulting primarily from the high degree of plasticity of its genome.
In one study, significant differences were found in two A. baumannii clinical isolates taken from
the same patient one week apart (Hornsey et al., 2011). One strain was taken prior to the patient
beginning tigecycline therapy, while the other was obtained one week afterwards. During a
single week, this organism accumulated a number of mutations within its genome that conferred
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resistance to many antibiotics, including tigecycline (Hornsey et al., 2011). Studies such as this
demonstrate the rapid evolution that A. baumannii is able to undergo in a very short time.
In the past, clinical isolates of A. baumannii were successfully treated with
aminoglycosides, β-lactams, quinolones, and tetracyclines including genatmicin, minocycline,
nalidixic acid, ampicillin, or carbenicillin; these antibiotics were successful in treating infections
until resistance to these antibiotics was noted around 1975 (Bergogne-Bérézin & Towner, 1996).
According to an article written by Bergogne-Bérézin and Towner in 1996, carbapenems such as
imipenem and meropenem were the therapies of choice for A. baumannii infections. At this
time, carbapenems were effective on “100% of strains” (Bergogne-Bérézin & Towner, 1996).
However, the same is not true today; in a study conducted from 2008-2011 in a university
hospital, 76% of A. baumannii isolates were resistant to meropenem and 79.5% of A. baumannii
isolates were categorized as multi-drug resistant (Townsend et al., 2015). Although carbapenem
resistance is quite common today, carbapenems are typically still considered the drug of choice.
When carbapenem resistance is detected, treatment usually changes to include either sublactam
or polymyxins, such as colistin (Peleg et al., 2008). However, resistance to each of these classes
has also been reported. In fact, pan-drug resistant strains of A. baumannii, resistant to all current
antibiotics, have also been reported (Peleg et al., 2008). If one becomes infected with a pan-drug
resistant strain, no current antibiotic could be used for therapy.
While little clinical information exists about A. baumannii before the 1970s, it is widely
assumed that the species was sensitive to most antibiotics. Because Acinetobacter infections
were likely easily treatable, it was not regarded as a threat. Beginning in Europe in the early
1980s, documented hospital outbreaks of A. baumannii were described in England, France,
Germany, Italy, Spain, and the Netherlands (Peleg et al., 2008). The subsequent spread A.
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baumannii infection across the world is likely due to transportation and travel of colonized
patients. In 1991 and 1992, outbreaks of carbapenem-resistant A. baumannii were reported from
a New York City hospital; these strains were multi-drug resistant, only susceptible to polymyxins
and ampicillin-sublactam. Since this time, this pathogen has been prominent in United States
hospitals; the National Nosocomial Infection Surveillance system reported significant increases
in resistance to amikacin, ceftazidime, and imipenem from 1986 to 2003 in the United States.
However, the prominence of A. baumannii was especially noted beginning in March 2003,
following the Iraq war. At this time, a number of soldiers suffered infected battle wounds due to
this organism, leading to the nickname “Iraqibacter.” This organism was later determined to
have not been obtained from the environment or during battle, but rather from infected surfaces
in field hospitals (Howard et al., 2012).
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V. ANALYSIS OF ACINETOBACTER BAUMANNII
The relationship between bacteriophages and Acinetobacter baumannii has never been
documented in scientific literature. Due to the correlation between phage elements and
virulence—such as antibiotic resistance—in a number of other organisms, including Escherichia
coli, Vibrio cholerae, Pseudomonas aeruginosa, Shigella dysenteriae, Salmonella enterica, and
Streptococcus pyogenes (Chen et al., 2005; Fortier & Sekulovic, 2013; Hosseinidoust, van de
Ven, & Tufenkji, 2013; Wagner & Waldor, 2002) I hypothesize that the acquisition of cryptic
prophage elements within the Acinetobacter baumannii genome corresponds to the sudden
increase in virulence and rapid evolution observed in this organism. Because A. baumannii is
distinctly different from other species of Acinetobacter, which are not normally pathogenic, the
acquisition and harboring of phage elements may correlate to the pathogenic potential of A.
baumannii in contrast to non-baumannii Acinetobacter species. The inclusion of cryptic
prophages within the genome throughout the history of A. baumannii may suggest that this
species has undergone purifying selection in order to maintain and contribute to the rapid rise in
virulence. Phage elements may also serve as active regulatory switches in A. baumannii, as they
do in other species (Feiner et al., 2015).

a. Discovery of Novel Genetic Material
Two clinical isolates of A. baumannii, BR097 and BU310 were analyzed in order to
better understand the pathogenicity of this organism. Both isolates were obtained from a single
patient in 2012, although each is a different strain; BR097 was isolated from a respiratory
specimen, while BU310 was isolated from urine. Because significant genotypic and phenotypic
differences, it is assumed that each isolate was obtained independently of the other. The whole
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genome shotgun sequencing projects for each specimen can be accessed through the NCBI
database (Accession numbers NZ_JNFY00000000.1 and NZ_JNFZ00000000.1).
When A. baumannii strains BR097 and BU310 were first analyzed, the two strains were
aligned against a reference strand of A. baumannii (ATCC 17978), isolated in 1951, to begin to
analyze the differences in each. A. baumannii ATCC 17978 (Accession: NZ_CP018664.1) was
previously completed to produce a whole chromosomal sequence, while the sequences of both
BR097 and BU310 were incomplete. By aligning the contiguous segments of BR097 and
BU310 to strain ATCC 17978, a draft quality chromosomal sequence was established for both
strains. Alignment was achieved by using online bioinformatic software; both RAST: Rapid
Annotation Using Subsystem Technology (Aziz et al., 2008; Brettin et al., 2015; Overbeek et al.,
2014) and Mauve (A. C. E. Darling, Mau, Blattner, & Perna, 2004; A. E. Darling, Mau, & Perna,
2010) were utilized to establish alignment.
Upon alignment of these different isolates, a number of gaps were present within the
chromosomal map (Figure 2). Such gaps represented DNA that was not contained in the
reference A. baumannii ATCC 17978 genome. Indeed, this DNA was novel genetic information
contained within the genomes of A. baumannii BR097 and BU310. Because it was not contained
in the original reference strain of A. baumannii from 1951, it is likely that this information was
either acquired through evolution prior to appearing in these two isolates or this information was
acquired directly by these two isolates by mechanisms such as lateral gene transfer.

b. Identification of Phage Genes
These novel sequences were then annotated to determine where they originated and to
understand the role they played in A. baumannii. A number of software programs were used to
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identify code determining sequences and open reading frames contained within this DNA; those
sequences that potentially coded for proteins were further analyzed to understand what kind of
protein it codes for based on conserved domains, amino acid residues, transmembrane helices,
and signal peptides. Software used included BLAST: Basic Local Alignment Search Tool,
CDD: Conserved Domain Database Search, T-Coffee (Di Tommaso et al., 2011), WebLogo
(Crooks, Hon, Chandonia, & Brenner, 2004), TMHMM: Transmembrane Helix Hidden Markov
Models, SignalP, PSORT-b (Gardy et al., 2003), and Phobius (Kall, Krogh, & Sonnhammer,
2004).
After annotation and analysis, the majority of this novel DNA was determined to
originate from bacteriophages and code for phage-related functions based on sequence homology
and conserved domains. The PHAST (Zhou, Liang, Lynch, Dennis, & Wishart, 2011) and
PHASTER (Arndt et al., 2016) prophage search tools were used to identify areas of intact,
incomplete, and questionable prophage sequences from a library of prophage sequences. One
intact prophage and a number of incomplete prophages were identified in both strains BR097 and
BU310; they harbor an intact Psychrobacter Psymv2 phage as well as many incomplete
Acinetobacter Bφ-B1251 phages (Table 3 and 4).
Therefore, the acquisition of genetic information directly from bacteriophages has altered
the genetic makeup of these strains. The prophage-imposed diversity among these three strains
may represent clinically significant changes and account for the differences observed in A.
baumannii today.
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c. Analysis of Prophage Inclusion Among Other Acinetobacter baumannii Strains
In order to understand the evolutionary impact prophages may have on the development
and expansion of antibiotic resistance in A. baumannii, other previously sequenced strains were
analyzed to determine if they harbor prophage elements. The genomes of twenty-two clinical
isolates of Acinetobacter baumannii were obtained from the public databases of the National
Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/genome/) (Table
2). These strains were chosen to represent a continuum of time, isolated beginning in 1950
through today. Together, these twenty-two strains represent a diverse group of isolates, differing
in specimen source, geographical location, and antibiotic resistance patterns.
As before, the PHAST (Zhou et al., 2011) and PHASTER (Arndt et al., 2016) prophage
search tools were used to identify areas of intact, incomplete, and questionable prophage
sequences based on the number of genes present, the homology, and the function of the genes.
Those marked as “incomplete” or “questionable” harbored genes that were identified in a
specific phage, although not all of the genes of the bacteriophage are found within the bacterial
host. To properly classify each region, a score is generated (guidelines established by
phaster.ca); a score of 150 is considered a perfect score while scores of >90 are considered intact,
70-90 is considered “questionable,” and <70 is considered “incomplete” (Arndt et al., 2016;
Zhou et al., 2011).
After analysis, it was found that all but one strain of A. baumannii contained two or more
phage elements (Table 2). The one strain that did not contain phage genes, AYE, did acquire a
resistance island that accounts for its virulence (Howard et al., 2012). Resistance islands are
groups of resistance genes in a single segment of DNA that are passed horizontally between
bacteria; these mobile elements are continuously lost and gained. The CIP70.10 strain, isolated
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in 1950, contained two prophage elements (one intact and one incomplete) while the AB030
strain, isolated in 2014, contained fifteen prophage elements (four intact and eleven incomplete).
There is obvious difference between these strains isolated 64 years apart. As anticipated, other
A. baumannii strains isolated recently displayed similar patterns to our own isolates BR097 and
BU310; all of these strains have seemed to maintain defective prophages, as well as intact
prophages, within their genome.
With the exception of AYE, all other strains maintained at least one defective
(incomplete) prophage within their genome (Tables 3 & 4). However, these strains were less
likely to harbor intact prophages (Tables 3 & 4). Of the twenty-two isolates studied, six of the
strains carried no intact prophages. Among the strains that did contain an intact prophage, the
quantity of these phages was also significantly less than the number of incomplete prophage
elements maintained. Most strains only carry one intact prophage while multiple incomplete
elements are found in a single strain.

d. Relationship of Phage Domestication to Antibiotic Resistance and Virulence
Upon analyzing the placement of cryptic (incomplete) prophage elements within the
genomes of A. baumannii BR097 and BU310, a phage replication initiation protein (Inoviridae
protein Gp2) was identified that lied downstream from an RND multidrug efflux transporter and
membrane fusion protein, as well as a transcriptional regulator (AraC) (Figure 2). In order to
determine if phage genes had any effect on the antibiotic resistance potential within a strain, the
same twenty-two isolates were also analyzed to identify antibiotic resistance genes.
The Comprehensive Antibiotic Resistance Database (CARD) (card.mcmaster.ca) was
used to identify resistance genes by comparing the protein-coding sequences of an organism to
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the database of sequenced resistance genes (Jia et al., 2017). This program is able to identify
“perfect,” “strict,” and “loose” matches to known resistance genes. For this project, only
“perfect” matches were searched in order to maintain reliable identification across all strains.
Table 5 lists the resistance genes identified in each strain. These resistance genes contribute to
resistance of different antibiotics through differing means; Table 6 summarizes the number of
genes, the resulting resistance patterns, and the different mechanisms a strain may use to resist
antibiotics.

e. Analysis of Prophage Inclusion in Other Acinetobacter Species
As previously described, Acientobacter baumannii is the only true pathogen within the
genus Acinetobacter. With the exception of A. baumannii, other Acinetobacter species are
ubiquitous in nature. Nonpathogenic species can be isolated from almost any environmental
source, especially in soil, wastewater, and as human normal flora (Al Atrouni, Joly-Guillou,
Hamze, & Kempf, 2016; Peleg et al., 2008). There are currently 48 species of Acinetobacter
identified by the NCBI. A. nosocomialis, A. pittii, A. ursingii, A. haemolyticus, A. lwoffii, A.
parvus, A. junii have been implicated in a few isolated human infections, although they are not
typically considered human pathogens (Touchon et al., 2014).
The environment could potentially serve as a reservoir for antibiotic resistance in other
Acinetobacter species. Non-baumannii strains isolated from hospital sewage, agricultural runoff,
and polluted surface waters have been found to produce carbapenemase and extended-spectrum
beta lactamase (ESBL) enzymes (Al Atrouni et al., 2016). Resistance genes are easily spread in
the environment; Acinetobacter is particularly well-suited for the natural environment, as this
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genus is able to resist desiccation and can survive in unfavorable, nutrient-limited conditions for
long periods of time (Al Atrouni et al., 2016; Peleg et al., 2008).
If other Acinetobacter species are also capable of acquiring resistance mechanisms such
as antibiotic-inactivating enzymes, why is A. baumannii the only true pathogen? In order to
differentiate A. baumannii from other Acinetobacter species, other sequenced species of
Acinetobacter were also analyzed to determine their prophage content (Table 9). The PHAST
and PHASTER programs were utilized for this analysis. Due to their low degree of
pathogenicity, fewer strains of other species have been sequenced and made available through
the NCBI. Those that were available were analyzed, but represent an altered view of this
population, as many of these strains were involved in rare human infections and have hence been
studied.
After analysis, all but one strain (A. calcoaceticus PHEA-2) of non-baumannii
Acinetobacter spp. harbored an intact or incomplete prophage. Unlike most strains of A.
baumannii, these strains frequently only harbored a single phage that was often intact. The
diversity of phages identified in these strains presented with a much greater variety than those of
A. baumannii (Table 10). Phages identified from other Acinetobacter species included
Enterobacteria phage mEp235, Psychrobacter phage pOW20, Burkholderia phage phiE255,
Pseudomonas phage PhiCTX, Haemophilus phage SuMu, and many others. Acinetobacter
phage Bϕ-B1251 was isolated in nine of the twenty-one other species analyzed, a much lower
percentage than that of A. baumannii.
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VI. DISCUSSION
i. Acquisition of Novel Genetic Material
This data indicates that A. baumannii has acquired a significant amount of novel genetic
material and continues to evolve through the years. As previously determined by numerous
studies, the genome of A. baumannii has a high degree of plasticity and is easily made competent
(Imperi et al., 2011). Therefore, the genome of A. baumannii is expected to be in constant flux
as genetic changes occur. However, elements that remain within the genome despite these
perturbations likely are significant to the change in pathogenicity of this organism. In this study,
numerous changes were observed among these strains of A. baumannii; most of these changes
could not be tracked over time and were, therefore, temporary elements. Some of these changes
included acquisition of resistance genes that were not observed in other populations of this
organism, as well as loss of intact prophages. Despite the inherent variability among strains,
patterns were identified that were consistent among strains and are, therefore, significant.

ii. Integration of Phage Elements
Indeed, prophages represent the largest reservoir of variability in A. baumannii. While a
number of intact phages were identified, most of the phage genes that were discovered within the
genome of A. baumannii were, however, not intact phages. As the ultimate goal of a prophage is
lysis (extraction from the host genome), whether from lytic or lysogenic life cycles, the
perpetuation of prophages within the host genome is not expected to occur. Upon lysis,
prophage elements are typically rapidly excised from the host, leaving very little, if any, genetic
material behind. When mutations or deletions occur to the phage and it is no longer capable of
lysis, the remaining segments of the genome persist within the host genome. These defective
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“cryptic” prophages were commonly observed in A. baumannii, suggesting previous infection
with the same prophage.
When analyzing prophage elements, it was noted that A. baumannii strains BR097 and
BU310 tended to especially preserve segments coding for structural phage components including
those for major capsid, integrase, and tail proteins. These components are typically found on the
ends of intact prophages, assisting the phage with integrating into and extracting itself from the
host genome. This finding is consistent with other studies that identified that genes encoded in
the internal parts of a prophage, such as packaging genes, are more commonly removed than
other genes located on the outer edges of a prophage (Bobay et al., 2014). There is still no
explanation as to why these genes are conserved as opposed to others; future studies are needed
to elucidate the selective processes that occur to maintain these genes.
Such extraneous material within the genome of an organism was often believed to be a
negative event, compromising host fitness. Regardless of the type or function of the conserved
genes, it is known that the insertion of foreign DNA, specifically bacteriophage DNA, into the
bacterial chromosome certainly impacts the regulation and, therefore, function of bacteria. Ron
Feiner described the consequences of chromosomal disruption by bacteriophages in 2015; he
suggests that insertions into essential regions for function or regulation would not be tolerated
and would, therefore, not be passed along to other generations. However, these insertions may
be tolerated in situations where the integration of the phage would be among genes that were
non-essential or only required in specific conditions, such as virulence factors (Feiner et al.,
2015).
In A. baumannii BR097, phage insertion points were primarily in regions of the genome
rich in genes coding for antibiotic resistance, fimbiral adhesion, and pilus assembly proteins,
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among others. While these genes certainly influence the virulence of this organism, these genes
are not necessary for survival. Despite the disruptive connotation phage genes carry in these
accounts, they may not only be merely tolerated, but they may actually prove advantageous for
their host. The location of integration must certainly not interfere with viability, but as long as
the host is able to maintain or have very minimal detriment to its overall fitness, maintaining a
cryptic prophage does not harm a host. In fact, the interactions phage genes experience with
non-essential genes, such as virulence factors, may actually promote the expression of these
defenses.
Such observations have been noted in other pathogenic bacteria, including Shigella
dysenteriae, Salmonella typhimurium, and Salmonella typhi. In Shigella dysenteriae, the shiga
toxin genes are surrounded on each side by isolated phage genes. The same phenomenon also
occurs surrounding the sopE2 (involved in invasion of human epithelial cells) gene in S.
typhimurium and the sspH (promotes attachment to host cells) and pertussis-like toxin genes in S.
typhi (Canchaya et al., 2004). Other studies also suggest that the integration of phages within
genes and operons actually may function as regulatory switches (Feiner et al., 2015).
While further studies are indicated, numerous instances of phage proteins located next to
transcriptional regulators and antibiotic resistance genes, such as RND multidrug efflux pumps
were found within our two clinical isolates of A. baumannii, suggesting that the species A.
baumannii may experience similar phage interactions. One example is displayed in Figure 1. In
this instance, a gene coding for a phage replication initiation protein (Inoviridae Gp2) was found
upstream from genes coding for RND multidrug efflux pumps as well as transcriptional
regulators. The clustering of phage genes nearby host genes coding for virulence factors and
regulatory functions is likely not random. I theorize that the integration of phage genes in these
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areas alters the regulation and expression of virulence factors such as antibiotic efflux pumps.
Although all strains of A. baumannii inherently contain efflux pumps, those that are the most
virulent (i.e. antibiotic resistant), are more recent strains that have acquired more phage
elements, especially incomplete elements. Because phage genes are commonly found nearby
genes encoding virulence factors, it is likely that a relationship does exist.

iii. Prophage Inclusion in the Acinetobacter baumannii Population
Significant amounts of prophage content were also discovered in other global strains of
A. baumannii. Among the twenty-two isolates of A. baumannii that were studied, notable
differences in geographic location, date of collection, and type of infection exist. However,
similarities and trends can be discerned within the whole population, despite the apparent
variance.
Both intact and incomplete prophage elements were found in A. baumannii strains,
although the inclusion of incomplete elements was much more pervasive; incomplete elements
were found in greater numbers and incomplete elements were even discovered in genomes that
lacked intact prophages (see LAC-4 and BJAB0868). Cryptic (incomplete) prophages were
observed in all but one strain (AYE), as previously discussed. In the twenty-one strains
containing cryptic prophages, all harbored at least one element originating from Acinetobacter
phage Bϕ-B1251 (also referred to as YMC/09/02/B1251).
The consistency observed in carrying prophage elements derived from this specific phage
suggests that A. baumannii may have a preference for maintaining it. This is likely not random;
as other studies have suggested, such similarity often results from a single ancestral phage
insertion or from multiple integrations of the same phage over time (Bobay et al., 2014). As
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discussed earlier, it is particularly unlikely for an intact phage to persist within a genome for long
periods of time, as they will eventually lyse and kill their host. Intact prophages are also subject
to rapid degradation by the host with time. Once defective, the phage carcass remains within the
host. Because the same defective prophage continues to be found across the majority of strains,
beginning as early as 1951 and continuing through today, it is probable that some of these
elements were maintained through replication and evolution. Since they are not lost from the
genome through lysis, they are more likely to be maintained as long as they do not confer a
considerable fitness burden for the cell.

iv. Relationship of Phage Domestication to Antibiotic Resistance and Virulence
Mechanisms of antibiotic resistance are not always straightforward and may require
phenotypic testing to truly elucidate resistance profiles. Some bacteria are intrinsically resistant
to certain antibiotics based on physical characteristics—due to differences such as thick
peptidoglycan cell walls in Gram positive bacteria and lipopolysaccharide in Gram negative
bacteria—they may have indirect means of resisting antibiotics (such as forming biofilms or
decreasing the number of porins), or they may acquire mutations to existing resistance
mechanisms or regulatory pathways (Adams, Chan, Molyneaux, & Bonomo, 2010; Hornsey et
al., 2011; Munita & Arias, 2016).
Consequently, it is nearly impossible to interpret an organism’s resistance capability
based solely on genomic studies. Phenotypic susceptibility studies are often necessary to
determine a resistance profile, as performed by clinical microbiology laboratories. Therefore,
analysis by the CARD list was not comprehensive and does not consider intrinsic resistance,
secondary mechanisms, and altered proteins (such as pbps—penicillin binding proteins).
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However, the resistance profiles obtained from the CARD database can still provide an adequate
surmise toward the actual resistance profiles of each strain.
Overall, A. baumannii does continue to constantly acquire new resistance genes with
time. The specific genes it acquires also changes with time, likely in response to changing
recommended antibiotic regimens. Older resistance genes are sometimes lost or are replaced.
One notable trend was the eventual elimination of adeR from the genome of A. baumannii
isolates (Table 5). This gene regulated antibiotic resistance to tetracyclines and aminoglycoside
antibiotics by regulating the adeABC efflux pump (CARD, Table 7)(Higgins, Schneiders,
Hamprecht, & Seifert, 2010). adeR was commonly found in the A. baumannii genome from
1951-2004, but the last time it was seen in a representative A. baumannii genome was 2008
(Table 5). This change was actually due to a novel mutation within the adeR gene, impacting its
regulation of the adeABC efflux pump and resulting in overexpression of adeABC and,
therefore, increased resistance to tetracycline and aminoglycoside antibiotics (Higgins et al.,
2010). Tigecycline is currently a popular choice in therapy against A. baumannii, but its
effectiveness is now jeopardized because of this mutation.
This is just one example of the various mutations and mechanisms A. baumannii has
acquired to become more virulent. Due to the complexity of genetic interactions and factors
associated with antibiotic resistance, it is difficult to attribute the rise of antibiotic resistance in
A. baumannii solely to the acquisition of cryptic prophage elements. However, antibiotic
resistance continues to increase, paralleling the increase in cryptic prophage elements in A.
baumannii. A connection between these two elements may, indeed, exist, but the exact
mechanism is unable to be discerned at this time.
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v. Prophage Inclusion in Other Acinetobacter species
Among the genus Acinetobacter, A. baumannii is the only true pathogen—but what
accounts for this difference? While other species are capable of causing human infections, they
predominantly remain susceptible to most antibiotics. Numerous studies have failed to
understand why the lifestyle of A. baumannii is distinctly unique. A number of theories have
been proposed, including unique gene clusters (including genes coding for integrases, type IV
secretion systems, pilus biogenesis, iron uptake, and metabolism functions) (Peleg et al., 2008)
as well as differences in transcriptional regulators (Adams et al., 2010). These propositions may
be true, but it is possible that these differences may even have originated from phages.
Bacteriophages are one of the largest vehicles of horizontal gene transfer and, by definition,
introduce foreign DNA into organisms; it is not unlikely that this is how A. baumannii acquired
these differences and, as a consequence, became more virulent.
Phage domestication by purifying selection certainly seems to occur in A. baumannii, but
other scientists studying this organism have overlooked this basic concept. The implications of
increasing phage content seem to have been previously dismissed by this scientific community.
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VII. CONCLUSIONS
Our community is not immune to the effects of antibiotic resistance, including that
caused by Acinetobacter baumannii. Everyone’s life is impacted by this threat, whether evident
or not; our healthcare bills continue to increase, infections become more devastating, treatments
no longer exist, and we are left defenseless against an enemy we once easily controlled. A.
baumannii has established its place in our community whether we recognize it or not. As seen in
by the clinical data in Table 1, A. baumannii continues to cause a steady number of hospital
infections. This organism will not be eradicated anytime soon. The data, however, does not
reflect the changes this species has undergone; the strains we encounter today are often
significantly more virulent, and, therefore, more deadly than those of previous years.
A. baumannii has undoubtedly experienced changes over time, most notably by
acquisition of phage genes. Within the A. baumannii species, increasing numbers of prophage
elements are acquired throughout its evolution. When the first strain of this organism, isolated in
1950, was sequenced, it contained only minimal prophage content. Significant differences are
observed in the most recently isolated strains. The total amount of genetic material obtained
from bacteriophages (Graph 1) continues to rise exponentially from 1950 to today. Similar
patterns are seen in prophage content solely from defective (incomplete) prophages (Graph 2), as
well as prophage content exclusively from Acinetobacter phage Bφ-B1251 (Graph 3). These
patterns are remarkably similar because of the total prophage content harbored in strains of A.
baumannii, the majority of the content is due to incomplete prophages. Also, among the
inclusion of cryptic prophages, the majority of these defective prophage remnants originated
from Acinetobacter phage Bφ-B1251. Relatively consistent numbers of intact prophages are
maintained, as they are continually gained and removed from the organism’s DNA. Therefore,
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intact prophages have no true impact on the evolution of this species; prophages only impact A.
baumannii once they have lost their function and become cryptic. Even when such mutations
occur, A. baumannii still appears to maintain selective pressure over the specific elements it
retains.
This single species is strikingly different than other species within the genus
Acinetobacter. The most obvious difference between this true pathogen and the environmental
species it is closely related to appears to be delineated by prophage content. While nonbaumannii species certainly also harbor phages, as most bacteria do, these phages and phage
conservation patterns differ from those of A. baumannii. This species has undoubtedly
maintained a significant amount of defective prophages—an occurrence that is only occasionally
observed in other Acinetobacter species. Whether A. baumannii is inherently more competent
than other species, and thus is more prone to acquisition of foreign DNA, is not clear. Despite
some minor variability, one common theme exists: A. baumannii, distinctively different from
other species of Acinetobacter, maintains a preference for genes originating from Acinetobacter
phage Bϕ-B1251. This particular phage is found in environmental strains as well, but not as
significantly as A. baumannii. This phage may not be conserved or selected for in these species
because it does not confer benefit. Alternatively, these species may first be selecting for the
benefits this phage may bestow. Because non-baumannii Acinetobacter species are first being
recognized as causative agents of human infection, it is possible that this trend is due to the
recent acquisition of incomplete Bϕ-B1251 elements. However, many more strains must be
sequenced in order to analyze this theory.
As evidenced by Tables 5-7, A. baumannii continues to acquire antibiotic resistance
determinants and virulence factors. The changes in resistance profiles vary among strains, but
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one pattern is consistent: this species is becoming more resistant every year. During this time, it
continues to be exposed to other phages, but seems to maintain preference for the Bϕ-B1251
phage genome. Our data demonstrates that the maintenance of Bϕ-B1251 phage elements
corresponds with A. baumannii’s growing antibiotic resistance patterns. The unique inclination
towards maintaining Bϕ-B1251 phage elements differentiates A. baumannii from other species of
Acinetobacter that only rarely cause human infections and do not possess the same degree of
pathogenicity as A. baumannii. Therefore, this difference is truly noteworthy.
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VII. FUTURE DIRECTIONS AND IMPLICATIONS
Antibiotic resistant bacteria are inescapable in healthcare, and much attention has been
given towards the discovery of novel therapeutics to kill pathogenic bacteria. One popular
alternative suggests using bacteriophages as predacious agents (Abedon, 2014). Bacteriophages
only are capable of killing their bacterial host and pose no harm to humans, as opposed to many
toxic antibiotics. Phage therapy has been shown to be promising for a number of infections,
especially against biofilm-producing organisms that are difficult to treat using antibiotics
(Semler, Lynch, & Dennis, 2011; Waters et al., 2017). In 2012, Drs. Jongsoo Jeon and Jae-won
Kim published an article suggesting the use of Acinetobacter phage YMC/09/02/B1251 ABA AP
(synonymous to phage Bϕ-B1251) as therapy for A. baumannii infections. They noted that this
phage was successful in killing a strain of carbapenem-resistant A. baumannii and concluded that
this phage would be useful in treating patients with sepsis due to multi-drug resistant A.
baumannii (Jeon, Kim, Yong, Lee, & Chong, 2012).
However, because this phage was found to lie defective within the genomes of a majority
of sequenced A. baumannii isolates, this bacteriophage does not always behave as we might
expect. The mutations we observed in A. baumannii represent the consequences that may result
when a phage is incapable of producing lysis. Rather than killing bacteria, prophages (once
defective) may actually cause bacteria to become more virulent. Careful consideration must
especially be given to the Bϕ-B1251 phage if used as therapy. This single phage, as opposed to
numerous others known to infect A. baumannii, is often maintained by this organism.
The interactions between bacterial pathogens and bacteriophages are not as simple or
straightforward as some may believe them to be. More respect must be shown towards
bacteriophages and their important role in bacterial evolution. Deliberately introducing
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pathogenic bacteria to bacteriophages within the human biome may not only be ineffective, but
catastrophic.
Hope, however, should not be lost. Numerous alternatives to antibiotics are now being
tested. These include initiatives such as utilization of the CRISPR/Cas9 system to resensitize
bacteria to antibiotics, competition by predatory bacteria, exposure of pathogens to UV light, or
even vaccination against anticipated bacterial threats. As explained above, just as caution must
be exercised before accepting bacteriophages as a means of therapy, all of these new alternatives
must be well understood before being implemented in healthcare. Just as the development of
antibiotics had consequences we are facing today, other unforeseen consequences may result
from the use of these new therapies. With careful study, scientific discourse, and the expanding
pool of resources available today, a community of scientists will be able to elucidate the best
future therapy. Studies such as ours are essential to provide more information about possible
consequences as we proceed through this journey.
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Table 1. Numbers and Types of Infections due to Acinetobacter baumannii by Year at a Single
Hospital in Louisville, KY
2010

2011

2012

2013

2014

2015

2016

Blood Cultures
Anaerobic
Body Fluids
Bone
Catheter tip
Cerebral Spinal
Fluid
Duodenal
Eye/Ear
Genital
Respiratory
Tissue
Urine
Wound

13
8
12
0
2
1

10
15
3
2
3
0

17
19
3
0
1
0

15
10
1
0
2
0

12
15
0
0
4
0

15
18
1
0
0
1

16
19
0
0
2
0

0
0
0
37
7
19
20

0
0
0
95
3
21
26

0
3
0
66
11
21
29

0
2
0
52
8
18
35

0
1
0
34
5
14
20

1
1
1
29
9
18
36

0
1
0
43
8
30
47

Total Number per
year

119

178

170

143

105

130

166

% in
2016
9.6
11.4
1.2

0.6
25.9
4.8
18
28.3
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Table 2. Clinical isolates of Acinetobacter baumannii used for analysis
Date Isolated

Strain*

Source

Location

1950
1951
1982
1994
1/2/1997
2001
2004
2005
4/20/2006
3/1/2007
2007
10/19/2008
2009
2010
3/1/2010
7/31/2011
7/14/2012
10/28/2012
11/8/2012
2013
5/29/2014
8/29/2014

CIP70.10
ATCC 17978
A1
AB307-0294
LAC-4
AYE
AB0057
ACICU
MDR-ZJ06
BJAB0868
TCDC-AB0715
D36
XH860
XH857
XH858
AC29
Ab04-mff
BU310
BR097
IOMTU433
XH386
AB030

Skin
Cerebrospinal Fluid
Unknown
Blood
Hospital Outbreak
Urine
Blood
Cerebrospinal Fluid
Blood
Ascites
Unknown
Hospital Outbreak
Unknown
Sputum
Sputum
Endotracheal Aspirate
Blood
Urine
Sputum
Unknown
Sputum
Blood

United States
France
United Kingdom
Buffalo, New York
Los Angeles, California
France
Washington DC
Rome, Italy
Zhejiang, China
Beijing, China
Taiwan
Sydney, Australia
Hangzhou, China
Guangdong, China
Zhejiang China
Malaysia
Edmonton, Canada
Louisville, Kentucky
Louisville, Kentucky
Nepal
Hangzhou, China
Winnipeg, Canada

*Strains obtained from the NCBI database (https://www.ncbi.nlm.nih.gov/genome/)
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Table 3. Analysis of Prophage Elements within Bacterial Chromosomes1 Among Strains
STRAIN

Total
Phage
Elements2

Intact
Acinetobacter
phage BφB1251

Incomplete
Acinetobacter
phage BφB1251

Total
Intact
Prophages

Total
Incomplete
Elements

CIP70.10
ATCC 17978
A1
AB307-0294
LAC-4
AYE
AB0057
ACICU
MDR-ZJ06
BJAB0868
D36
XH860
XH857
XH858
TCDC-AB0715
AC29
Ab04-mff
BU310
BR097
IOMTU433
XH386
AB030

2
3
4
2
4
0
6
3
5
3
5
4
3
5
8
3
4
10
5
5
5
15

0
1
2
1
0
0
1
2
3
0
2
0
1
0
1
1
1
0
0
2
1
2

0
1
1
0
2
0
3
1
0
2
0
3
0
3
3
2
2
6
4
1
1
3

1
1
2
1
0
0
1
2
4
0
4
1
1
1
2
1
1
1
1
2
3
4

1
2
2
1
4
0
5
1
1
3
1
3
2
4
6
2
3
9
4
3
2
11

1
2

No plasmid data is included in analysis
Number obtained from PHASTER
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Table 4. Prophages Other than Acinetobacter phage Bφ-B1251 Found
STRAIN
CIP70.10
ATCC 17978
A1
AB307-0294
LAC-4

Other Intact Prophages
Mannheimia phage vB MhM
3927AP2
Enterobacteria phage mEp235
Psychrobacter phage pOW20-A

Psychrobacter phage pOW20-A
Stx2-converting phage 1717
Pelagiphage HTVC010P

AYE
AB0057
ACICU
MDR-ZJ06
BJAB0868
D36
XH860
XH857
XH858
TCDC-AB0715
AC29
Ab04-mff
BU310

Cronobacter phage ENT39118
Acinetobacter phage AP22
Haemophilus phage SuMu

Enterobacteria phage SfV

Mannheimia phage vB MhM
3927AP2
Psychrobacter phage Psymv2
Enterobacteria phage mEp235

Burkholderia phage phi6442

Mannheimia phage vB MhM
3927AP2
Mannheimia phage vB MhM
3927AP2

Psychrobacter phage Psymv2

BR097
IOMTU433

Psychrobacter phage Psymv2

XH386

Enterobacteria phage mEp235
Salmonella phage SEN34
Enterobacteria phage mEp235
Enterobacteria phage mEpx2

AB030

Other Cryptic Prophages
Pseudomonas phage Pf3

Escherichia phage PA2
Enterobacteria phage P1
Escherichia phage PA2
Pseudomonas phage F116
Psychrobacter phage pOW20-A
Salmonella phage F11SE
Myxococcus phage Mx8
Megavirus chiliensis
Invertebrate iridescent virus 6
Faustovirus
Acinetobacter phage AP22
Enterobacteria phage mEp235
Enterobacteria phage mEp235
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Table 5. Resistance Genes Identified in Acinetobacter baumannii Strains by CARD*
1950
1951
1982
1994

CIP70.10
ATCC 17978
A1
AB307-0294

1997
2001

LAC-4
AYE

adeK, mexT, OXA-64
adeK, adeR
adeK, adeR, adeA, abeS, aadA, catI, mexT, OXA-69
adeK, adeI, adeA, abeS, mexT, OXA-69

2007
2008

adeK, adeI, abeS, mexT, sul2, OXA-68, OXA-235
adeK, adeI, adeR, adeA, abeS, aadA, arr-2, catI, dfrA10, mexT,
OXA-10, OXA-69, APH (3')-la, VEB-1
AB0057
adeK, adeR, adeA, abeS, aadA, catI, mexT, OXA-69, OXA-23, APH
(3')-la, TEM-1
ACICU
adeK, abeS, mexT, OXA-66, sul1
MDR-ZJ06
aadA, calB6, OXA-23, OXA-66, sul1
TCDC-AB0715 aadA, abeS, catB8, mexT, OXA-23, OXA-66, sul1, sul2, TEM-1,
APH(3')-la
BJAB0868
abeS, ADC-2, mexT, OXA-23, TEM-1
D36
adeK, adeI, adeR, adeA, abeS, mexT, OXA-23, OXA-69

2009
2010

XH860
XH857

2010
2011
2012

XH858
AC29
Ab04-mff

2012
2012

BU310
BR097

2013

IOMTU433

2014

XH386

2014

AB030

2004
2005
2006
2007

adeK, adeI, abeS, mexT, OXA-23, OXA-66, APH(3')-1a
abeS, aadA, armA, catB8, mexT, msrE, OXA-23. OXA-66, sul1,
TEM-1, APH (3')-la
adeK, abeS, mexT, OXA-23, OXA-68
adeK, abeS, armA, mexT, msrE, OXA-66, APH (3')-la, TEM-1
adeK, adeI, abeS, mexT, OXA-23, OXA-68, sul2
abeS, mexT, OXA-95
adeK, adeI abeS, aadA, armA, catB8, mexT, msrE, OXA-23, OXA24, OXA-66, OXA-95, sul1, APH (3')-Ia, TEM-1
adeK, adeI, mexT, NDM-1, OXA-23, OXA-104, bleomycin
resistance protein (BRP)
adeI, abeS, aadA, armA, CATB8, mexT, msrE, OXA-23, OXA-66,
sul1, TEM-1, APH(3')-la
adeK, abeS, mexT, OXA-23, OXA-65, sul2, TEM-1

*CARD data was limited to perfect matches; strict and loose matches were not included in this
analysis

CIP70.10
1
2
2
2
1
1
1
1
2
1

ATCC
17978
1
1
1
1
1
1
1
2
1

A1
1
2
3
2
1
1
1
2
2

AB3070294
2
3
3
3
2
2
2
3

LAC-4
2
4
3
3
2
2
2

AYE
2
2
5
4
3
2
2

AB0057
1
2
3
3
2
1

ACICU
1
2
2
2
1

1
2
1

2
3
2
1

3
1
1

4
3
3
2
2
2

1

5

3

3

2

2

2

3

3

1

3

2

2

1

1

1

3

2

2

1

2

1

4

3

3

2

2

2

XH860

2

2
1

2

1

GLYCOPEPTIDE RESISTANCE

2
1

2
1

3
5
2

3
1
5
1

2
3
2
1
4
1

3
4
4
7
1
6
2

1
1
3
2
6
5
2

1
1
1
2
1
1
3
1

4
1

1
6
2
2
1

1
3
2
1

4
3
2
6
2

2

3

4

4

1

3

1

3

1

4

1

4

1

1
1

1

6

1

2

2

1

2

3

2

3

2

1

1

1

GENE INVOLVED IN ANTIBIOTIC
SEQUESTRATION

ANTIBIOTIC TARGET REPLACEMENT PROTEIN

ANTIBIOTIC TARGET MODIFYING ENZYME

SULFONAMIDE RESISTANCE

STREPTOGRAMIN RESISTANCE

GENE MODULATING AX EFFLUX

2
1

EFFLUX PUMP CONFERRING RESISTANCE

D36
AMINOGLYCOSIDE RESISTANCE

ANTIBIOTIC INACTIVATION ENZYME

2
TRIMETHOPRIM RESISTANCE

Ab04-mff
TETRACYCLINE RESISTANCE

1
RIFAMPIN RESISTANCE

AC29
MACROLIDE RESISTANCE

1
LINCOSAMIDE RESISTANCE

XH858
FLUORQUINOLONE RESISTANCE

XH857
CHLORAMPHENICOL RESISTANCE

MDRZJ06
TCDCAB0715
BJAB086
8
BETA-LACTAM RESISTANCE

AMINOCOUMARIN RESISTANCE
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Table 6. Antibiotic Resistance Profiles and Mechanisms Conferred by Resistance Genes

43
BU310
BR097

3

IOMTU433
XH386
AB030

5

2

1

3
1

1

4
3

8

1
3

2

1

1

4

1

3

1

1

4

1

1

3

1

3
1

2

1

1

1
1

1

2

6
3

1

1
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Table 7. Descriptions of Resistance Genes Identified by CARD
Gene Name

Effects on Resistance

Description

aadA

antibiotic inactivation enzyme,
aminoglycoside resistance

abeS

efflux pump conferring resistance

ADC-2

beta-lactam resistance gene, antibiotic
inactivation enzyme
efflux pump conferring resistance,
tetracycline resistance gene

ANT(3'')-Ia is an aminoglycoside
nucleotidyltransferase gene encoded by
plasmids, transposons, integrons in
Enterobacteriaceae, A. baumannii, P.
aeruginosa and Vibrio cholerae
AbeS in an efflux pump of the SMR family
of transporters found in Acinetobacter
baumannii.
ADC-25 is a beta-lactamase found in
Acinetobacter baumannii.
AdeA is the membrane fusion protein of the
multidrug efflux complex AdeABC.

adeA
adeI

adeK

adeR
APH(3')-1a

armA

efflux pump conferring resistance,
tetracycline resistance gene, fluorquinolone
resistance gene, chloramphenicol resistace
gene, trimethoprim resistance gene, betalactam resistance gene, macrolide resistance
gen, aminocoumarin resistance gene,
lincosamide resistance gene, rifampin
resistance gene
efflux pump conferring resistance,
tetracycline resistance gene, fluorquinolone
resistance gene, chloramphenicol resistace
gene, trimethoprim resistance gene, betalactam resistance gene, macrolide resistance
gen, aminocoumarin resistance gene,
lincosamide resistance gene, rifampin
resistance gene
gene modulating antibiotic efflux, efflux
pump conferring resistance, tetracycline
resistance gene
antibiotic inactivation enzyme,
aminoglycoside resistance

aminoglycoside resistance gene, antibiotic
target modifying enzyme

AdeI is the membrane fusion protein of the
AdeIJK multidrug efflux complex.

AdeK is the outer membrane factor protein in
the adeIJK multidrug efflux complex.

AdeR is a positive regulator of AdeABC
efflux system. AdeR inactivation leads to
susceptibility to aminoglycoside antibiotics
APH(3')-Ia is a transposon-encoded
aminoglycoside phosphotransferase in E. coli
and S. enterica. It is identical at the protein
sequence to APH(3')-Ic, an aminoglycoside
phosphotransferase encoded by plasmids,
transposons and genomic islands in K.
pneumoniae, A. baumannii, S. marcescens,
Corynebacterium spp., Photobacterium spp.
and Citrobacter spp.
ArmA is a 16S rRNA methyltransferase that
targets mature or nearly mature 30S subunits.
It transfers a methyl group from S-adenosylL-methionine to N7-G1405 of the 16S
rRNA, an aminoglycoside binding site.
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arr-2

antibiotic inactivation enzyme, rifampin
resistance gene

BRP
(bleomycin
resistance
protein)
catB6

gene involved in antibiotic sequestration,
glycopeptide resistance gene
antibiotic inactivation enzyme,
chloramphenicol resistance

catB6 is a plasmid-encoded variant of the cat
gene found in Pseudomonas aeruginosa

catB8

antibiotic inactivation enzyme,
chloramphenicol resistance

catI

antibiotic inactivation enzyme,
chloramphenicol resistance

dfrA10

trimethoprim resistance, antibiotic target
replacement protein

catB8 is a plasmid or integron-encoded
variant of the cat gene found in Klebsiella
pneumoniae, Salmonella typhi and
Pseudomonas aeruginosa
catI is a chromosome and transposonencoded variant of the cat gene found in
Escherichia coli and Acinetobacter
baumannii
dfrA10 is an integron-encoded dihydrofolate
reductase found in Klebsiella pneumoniae

mexT

efflux pump conferring antibiotic resistance,
gene modulating antibiotic efflux

msrE

efflux pump conferring resistance,
macrolide resistance gene, streptogramin
resistance gene

NDM-1

beta-lactam resistance gene, antibiotic
inactivation enzyme, meropenem,
imipenem, carbapenem, cephalosporin
resistance
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme

OXA-10
OXA-23
OXA-24
OXA-64
OXA-66
OXA-68
OXA-69
OXA-95
OXA-104

arr-2 is an integron-encoded
ribosyltransferase found in Pseudomonas
aeruginosa
A diverse set of acidic proteins that are able
to complex bleomycin and thus prevent
bleomycin-induced DNA cleavage

MexT is a LysR-type transcriptional
activator that positively regulates the
expression of MexEF-OprN and OprD.
MsrE is an ABC-efflux pump expressed to
Klebsiella pneumoniae that confers
resistance to erythromycin and streptogramin
B antibiotics. It is associated with plasmid
DNA.
NDM-1 is a metallo-beta-lactamase isolated
from Klebsielle pneumoniae with nearly
complete resistance to all beta-lactam
antibiotics
OXA-10 is a beta-lactamase found in
Acinetobacter baumannii and P. aeruginosa
OXA-23 is a beta-lactamase found in A.
baumannii
OXA-24 is a beta-lactamase found in A.
baumannii and P. aeruginosa
OXA-64 is a beta-lactamase found in A.
baumannii
OXA-66 is a beta-lactamase found in A.
baumannii
OXA-68 is a beta-lactamase found in A.
baumannii
OXA-69 is a beta-lactamase found in A.
baumannii
OXA-95 is a beta-lactamase found in A.
baumannii
OXA-104 is a beta-lactamase found in A.
baumannii
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OXA-235
sul1

beta-lactam resistance gene, antibiotic
inactivation enzyme
antibiotic target replacement
protein,sulfonamide resistance gene

sul2

antibiotic target replacement
protein,sulfonamide resistance gene

TEM-1

beta-lactam resistance gene, antibiotic
inactivation enzyme
beta-lactam resistance gene, antibiotic
inactivation enzyme

VEB-1

OXA-235 is a beta-lactamase found in A.
baumannii
Sul1 is a sulfonamide resistant
dihydropteroate synthase of Gram-negative
bacteria. It is linked to other resistance genes
of class 1 integrons.
Sul2 is a sulfonamide resistant
dihydropteroate synthase of Gram-negative
bacteria, usually found on small plasmids.
TEM-1 is a broad-spectrum beta-lactamase
found in many Gram-negative bacteria
VEB-1 is a beta-lactamase found in
Escherichia coli and Pseudomonas
aeruginosa
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Table 8. Genomic Comparisons of Phages and Antibiotic Resistance Genes
Year Collected

A. baumannii Strain

1950
1951
1982
1994
1997
2001
2004
2005
2006
2007
2007
2008

CIP70.10
ATCC 17978
A1
AB307-0294
LAC-4
AYE
AB0057
ACICU
MDR-ZJ06
TCDC-AB0715
BJAB0868
D36

Number of Antibiotic
Resistance Genes
Identified
3
2
8
6
7
13
11
5
5
10
5
8

2009
2010
2010
2011
2012
2012
2012
2013
2014
2014

XH860
XH857
XH858
AC29
Ab04-mff
BU310
BR097
IOMTU433
XH386
AB030

7
11
5
8
7
3
15
7
12
7

1
1
2
1
0
0
1
2
4
0
4
1

Number of
Incomplete
Prophages
1
2
2
1
4
0
5
1
1
3
1
3

1
1
2
1
1
1
1
2
3
4

2
4
6
2
3
9
4
3
2
11

Number of Intact
Phages
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Table 9. Isolates of Other Acinetobacter Species Used for Analysis
Acinetobacter
Species
baylyi

Strain

calcoaceticus
calcoaceticus
gerneri

ADP1
DSM 14961 (CIP
107474)
PHEA-2
RUH2202
DSM 14967

haemolyticus

ATCC 19194

haemolyticus
johnsonii
johnsonii
junii
junii

TJS01
SH046
XBB1
65
SH205

lwoffii

SH145

nosocomialis
oleivorans
parvus
pittii
pittii
radioresistens
radioresistens
soli
ursingii

6411
DR1
NIPH 1103
ATCC 19004 (CIP 70.29)
AP 882
SH164
SK82
GFJ2
NIPH 706

baylyi

GenBank
Accession
Number
CR543861.1

Source
Soil

PRJNA183290

Activated sludge plant

CP002177.1
PRJNA38337
PRJNA224116
SAMN0191763
3
CP018871.1
PRJNA38339
CP010350.1
CP019041.1
PRJNA38341
SAMN0246373
1
CP010368.1
NC_014259
490813056

Industry wastewater
Skin flora
Activated sludge plant

CP014477.1
PRJNA38345
PRJNA34081
CP016896.1
491140751

CLINICAL-wound
GI flora
Skin flora
Industrial, soil
Blood

Nose flora
CLINICAL- respiratory
Skin flora
Hospital sewage
Limnetic water
GI flora
Skin flora
CLINICAL
Rice paddy soil
Skin flora
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Table 10. Prophage Content Found in Other Acinetobacter Species
Acinetobacter
Species
baylyi
baylyi
calcoaceticus
calcoaceticus
gerneri
haemolyticus
haemolyticus
johnsonii

Prophage
Elements
Identified by
PHASTER
1
1
0
1
1
1
2
1

Intact Prophages

Incomplete
Prophages

Questionable
Prophages

Psychro pOW20
Psychro pOW20
Acinet Bphi B1251
Burkho phiE255
Acinet Bphi B1251
Pectob PP90
Entero mEp235

Enterofi AA91

johnsonii

4

Pseduo PhiCTX

Paenib tripp

junii

2

junii

3

Acinet Bphi B1251

lwoffii
nosocomialis
oleivorans
parvus
pittii
pittii
radioresistens

2
1
2
1
1
1
2

Entero mEp235
Entero mEp235,
Stx2 c 1717
Shewan MR-1

radioresistens

5

soli

4

ursingii

1

Entero tyrion, Acinet
Bphi B1251
Paenib tripp

Acinet Bphi B1251
Pseudo JBD93
Acinet Bphi B1251

Entero cdtl
Pseudo B3
Burkho BcepMu

Cronob vB GAP32
Entero mEp235,
Acinet Bphi B1251
Manhe vB MhM
3927AP2
Haemop SuMu

Acinet Bphi B1251
Acinet Bphi B1251,
Ostreo 2
Phage phiJL001

Acinet Bphi B1251
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Phage Elements

Graph 1. Total Phage Elements. A. baumannii strains isolated after 2000 appear to have
steadily acquired more phage elements (both intact and incomplete prophages combined).
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Graph 2. Number of Incomplete Phages. A steady rise in the number of incomplete prophage
elements harbored by A. baumannii mirrors the rise in total phage elements (Graph 1). This rise
in phage elements seems to parallel the rise in antibiotic resistance.
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Graph 3. Number of Incomplete Bφ-B1251. Compared to Graphs 1 and 2, the increase in both
total phage elements and incomplete phages also mirrors the increase in incomplete Bφ-B1251
elements. This single phage seems to be the most well-maintained phage element and is
ubiquitous among a majority of A. baumannii strains.
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Graph 4. Total phage elements projected with exponential trendline. Because different
strains evolve at varying rates, only the most “evolved” strains were analyzed. Of these, a clear
exponential pattern of phage acquisition (both intact and incomplete) was discerned
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Graph 5. Number of incomplete phages projected with exponential trendline. Again, a clear
exponential pattern of incomplete phage acquisition was discerned, suggesting that the evolution
of A. baumannii in respect to prophage elements is due to incomplete, rather than intact,
prophages.
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Graph 6. Number of incomplete Bφ-B1251 phages projected with exponential trendline.
Finally, a clear exponential pattern of incomplete Bφ-B1251 phage maintenance was also
discerned. Therefore, of the incomplete phages contributing to A. baumannii diversity,
Acinetobacter phage Bφ-B1251 contributes the most to the exponential pattern we observe.
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Figures

Phage Capsid
and Scaffold

a.
Catalase

Phage
Replication
initiation
Protein;
Inoviridae
protein Gp2

S-(hydroxymethyl)
glutathione
dehydrogenase

Exinuclease ABC
subunit; DNA repair
(repeated from above)

b.

Exinuclease ABC
subunit; DNA repair

Two
component
response
regulator

RND multidrug efflux
transporter; Acriflavin
resistance protein
AdeT

RND Efflux System; Membrane
Fusion Protein CmeA
Transcriptional
Regulator, AraC
RND multidrug efflux
transporter; Acriflavin
resistance protein
(repeated from above)

Figure 1. Placement of phage genes nearby antibiotic resistance genes and transcriptional
regulators. Shown is contig 2 of A. baumannii BR097 bp 600679..622441 (begins at first line (a)
and continues down to next line (b)). In this example, a phage replication initiation protein is
located upstream from an RND multidrug efflux transporter and transcriptional regulator. Image
generated using RAST SEEDviewer.
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Figure 2. Genomic comparisons of A. baumannii BR097 and BU310 against reference strain A.
baumannii ATCC 17978. The outermost ring represents BR097, while the inner ring represents
the genome of BU310. The colors of each line within the ring (representing a gene within the
genome) correspond to the percent of homology, ranging from dark blue (100%) to red. Areas of
white represent novel genetic material that was not found within the reference genome and is,
therefore, unique to the genomes used for comparison.
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